81654-33-3

Upstream product

• 33469-37-3 2-(4-methoxyphenyl)-4-(trifluoromethyl)-imidazole 
• 120-20-7 2-(3,4-dimethoxyphenyl)-ethylamine 
• 33469-37-3 2-(p-methoxyphenyl)-4-(trifluoromethyl)imidazole 

Downstream Products

• 85648-06-2 (S) 2-[4-(3-cyclopropylamino-2-hydroxypropoxy)-phenyl]-4-trifluoromethylimidazole 
• 102152-26-1 (S)-4-bromo-2-<4-<3-<<2-(3,4-dimethoxyphenyl)ethyl>-amino>-2-hydroxypropoxy>phenyl>imidazole 
• 102152-27-2 (S)-4-hloro-2-<4-<3-<<2-(3,4-dimethoxyphenyl)ethyl>amino>-2-hydroxypropoxy>phenyl>imidazole 
• 102151-66-6 4-bromo-2-(p-hydroxyphenyl)imidazole 
• 102151-67-7 4-chloro-2-(4-hydroxyphenyl)imidazole 
• 102151-65-5 5-bromo-2-(p-methoxyphenyl)imidazole-4-carboxylic acid 

Relevant academic research and scientific papers

BETA-BLOCKING SUBSTITUTED IMIDAZOLES

Novel substituted imidazoles and methods for their preparation are disclosed. These imidazoles, and their salts, exhibit pharmacological activity which includes antihypertensive activity and β-adrenergic blocking activity.

BETA-ADRENERGIC BLOCKING IMIDAZOLYLPHENOXY PROPANOLAMINES

Substituted imidazoles and methods for their preparation are disclosed. These imidazoles, and their salts, exhibit pharmacological activity which includes antihypertensive activity and β-adrenergic blocking activity. STR1

β1-Selective Adrenoceptor Antagonists: Examples of the 2-phenyl>imidazole Class. 2

An attempt to develop a highly cardioselective β-adrenoceptor antagonist devoid of intrinsic sympathomimetic activity (ISA) focused on exploring structure-activity relationships around (S)--amino>-2-hydroxypropoxy>phen